NeuroOne Medical Technologies Corporation
General ticker "NMTC" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $28.9M (TTM average)
NeuroOne Medical Technologies Corporation follows the US Stock Market performance with the rate: 20.4%.
Estimated limits based on current volatility of 2.9%: low 0.67$, high 0.71$
Factors to consider:
- Earnings expected soon, date: 2025-12-16 bmo
- Total employees count: 17 (+6.2%) as of 2024
- Top business risk factors: Lack of profitability, Insufficient funding, Manufacturing risks, Cybersecurity threats, Intellectual property risks
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-09-30 to 2026-09-30
- 2024-09-30 to 2025-09-30 estimated range: [0.52$, 1.49$]
- 2025-09-30 to 2026-09-30 estimated range: [0.53$, 1.51$]
Financial Metrics affecting the NMTC estimates:
- Positive: with PPE of -2.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -42.93 <= 0.33
- Positive: Investing cash flow per share per price, % of -0.47 > -0.66
- Positive: Inventory ratio change, % of -3.65 <= -0.75
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 15.31 <= 18.93
- Positive: Interest expense per share per price, % of 0.89 <= 3.41
Short-term NMTC quotes
Long-term NMTC plot with estimates
Financial data
| YTD | 2022-09-30 | 2023-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Revenue | $0.17MM | $1.95MM | $3.45MM |
| Operating Expenses | $10.20MM | $13.91MM | $15.34MM |
| Operating Income | $-10.03MM | $-11.96MM | $-11.89MM |
| Non-Operating Income | $0.03MM | $0.10MM | $-0.43MM |
| Interest Expense | $0.00MM | $0.00MM | $0.23MM |
| R&D Expense | $4.93MM | $6.94MM | $5.07MM |
| Income(Loss) | $-10.00MM | $-11.86MM | $-12.32MM |
| Profit(Loss)* | $-10.00MM | $-11.86MM | $-12.32MM |
| Stockholders Equity | $9.60MM | $6.25MM | $0.82MM |
| Inventory | $0.70MM | $1.73MM | $2.64MM |
| Assets | $12.82MM | $8.10MM | $5.37MM |
| Operating Cash Flow | $-7.52MM | $-12.89MM | $-11.01MM |
| Capital expenditure | $0.28MM | $0.38MM | $0.12MM |
| Investing Cash Flow | $-3.24MM | $2.65MM | $-0.12MM |
| Financing Cash Flow | $12.02MM | $7.40MM | $7.27MM |
| Earnings Per Share** | $-0.63 | $-0.65 | $-0.46 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.